NHL: Avalanche star D Cale Makar to return vs. Ducks

Date:

Share post:


Colorado Avalanche defenseman Cale Makar will return to the lineup for Thursday’s game against the visiting Anaheim Ducks in Denver.

Makar has been sidelined with an upper-body injury for the Avalanche’s last four games. Although Colorado emerged victorious in all four contests to extend its winning streak to six games, Makar admitted it was difficult to see his team compete without him.

“That’s kind of a tough thing for me,” Makar said. “You watch your team go to battle, and you want to be with those guys. I love, obviously, playing hockey. So anytime I’m watching my team play it’s not a fun time. It’s not ideal to be out right now. I don’t look at it as in terms of I need that rest. It’s more so I want to be playing. It’s just a really unfortunate thing that happened, and I’ve just been trying to grind to get back.”

The reigning Norris and Conn Smythe Trophy recipient, Makar has 43 points (13 goals, 30 assists) in 42 games this season. He leads the NHL in ice time per game (27:09).

Makar has totaled 223 points (61 goals, 162 assists) in 220 career games since being selected by the Avalanche with the fourth overall pick in the 2017 NHL Draft.

–Field Level Media

spot_img

Related articles

NHL: Ducks F Trevor Zegras facing possible suspension

Anaheim Ducks forward Trevor Zegras is facing a possible suspension after Sunday's hit to the head of Detroit...

NHL: Soaring Jets host sinking Sharks, go for 10th consecutive win

The Winnipeg Jets will go for their 10th straight win when they host the slumping San Jose Sharks...

NHL: NHL roundup: Alex Ovechkin (hat trick) 13 from all-time goal mark

Alex Ovechkin continued his pursuit of Wayne Gretzky's goal-scoring record with his 32nd career hat trick as the...

NHL: Dylan Guenther tips in game-winner as Utah stops Canucks

Dylan Guenther's power-play goal with 5:53 left broke a tie and gave the Utah Hockey Club a 2-1...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.